OptiBiotix Health Plc

OptiBiotix Health Plc

Biotechnology Research

Better Science, Better Health... The OptiBiotix difference, improving health and wellbeing

About us

OptiBiotix was formed in March 2012 to develop compounds which modify the human microbiome - the collective genome of the microbes in the body - to prevent and manage human disease. The aim of OptiBiotix is to discover and develop microbial strains, compounds and formulations, which modulate the human microbiome and can be used as food ingredients and supplements or active compounds for the prevention and management of human metabolic diseases, examples of which include obesity, cholesterol and lipid distribution and diabetes. OptiBiotix has established a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The development pipeline is fuelled by its proprietary OptiScreen® and OptiBiotic® platform technologies designed to identify metabolic pathways and compounds that impact on human physiology and bring potential health benefits. These platforms are applicable across a wider range of other human diseases.

Industry
Biotechnology Research
Company size
2-10 employees
Headquarters
York
Type
Public Company
Founded
2012
Specialties
Biotechnology, Life sciences, Human micro biome, Cholesterol management, Disease prevention, Obesity prevention, Obesity management, Diabetes prevention, and Health & wellbeing

Locations

Employees at OptiBiotix Health Plc

Updates

Similar pages

Browse jobs

Funding

OptiBiotix Health Plc 2 total rounds

Last Round

Post IPO equity

US$ 1.7M

Investors

Graham Myers
See more info on crunchbase